3D printing a functional polypill: a practical manufacturing method?”, Presented by Clive Roberts, University of Nottingham. The processes used to produce tablets, the dominant form of medicine taken by patients, have changed relatively little for over a century. Whilst these approaches serve the industry and patients very well they remain limited and cannot create complex dosage forms or bespoke medications tailored for an individual or sub-population. This would be valuable in meeting therapeutic challenges and the need for personalized medicines. 3D printing, offers a route to address these issues. As an example I will show amongst other examples, a 3DP 5-drug polypill. The potential and challenges for using 3DP in the manufacture of medicines will be discussed.
About Clive Roberts
Research is focused on methods to develop new medicines (300+ publications). Over 25 years of experience in formulation methods and has aided the development of medicines with many companies. A co-founder of Molecular Profiles Ltd (now Juniper Pharmaceuticals, NASDAQ listed) and of Eminate Ltd, who have globally licenced low-salt formulations.
About University of Nottingham
The School was joint 1st in the UK on quality in the 2014 Research Excellence Framework and is the only School to have 100% of research at ‘InternationallyLeading’ in the ‘Impact on Society’ category. The School is ranked 8th in the QS World Rankings for pharmacy and pharmacology.